US BANCORP \DE\ - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$25,000
+177.8%
265
+72.1%
0.00%
Q3 2021$9,000
+12.5%
154
+31.6%
0.00%
Q2 2021$8,000
-63.6%
117
-63.7%
0.00%
Q1 2021$22,000
+15.8%
322
+27.3%
0.00%
Q4 2020$19,000
+90.0%
253
+97.7%
0.00%
Q3 2020$10,0000.0%128
-16.3%
0.00%
Q2 2020$10,000
+400.0%
153
+212.2%
0.00%
Q1 2020$2,0000.0%490.0%0.00%
Q4 2019$2,000
-80.0%
49
-77.1%
0.00%
Q3 2019$10,000
+900.0%
214
+791.7%
0.00%
Q2 2019$1,0000.0%240.0%0.00%
Q1 2019$1,0000.0%240.0%0.00%
Q4 2018$1,0000.0%240.0%0.00%
Q3 2018$1,0000.0%240.0%0.00%
Q2 2018$1,000
-92.9%
24
-93.1%
0.00%
Q1 2018$14,000
-6.7%
349
-19.8%
0.00%
Q4 2017$15,000
-40.0%
435
-56.8%
0.00%
Q3 2017$25,0001,0060.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Prosight Management, LP 163,133$7,467,0004.14%
PFM Health Sciences, LP 2,271,536$103,968,0003.07%
Partner Investment Management, L.P. 28,877$1,322,0002.26%
Atika Capital Management LLC 181,000$8,284,0001.74%
DAFNA Capital Management LLC 93,942$4,300,0001.62%
Asymmetry Capital Management, L.P. 16,272$745,0001.60%
First Light Asset Management, LLC 190,838$8,735,0001.32%
Perceptive Advisors 953,129$43,624,0001.18%
Rhenman & Partners Asset Management AB 155,000$7,094,0000.89%
Opus Point Partners Management, LLC 9,770$447,0000.81%
View complete list of ARENA PHARMACEUTICALS INC shareholders